Top Story

Cardiorespiratory fitness levels predict risk for cancer diagnosis, mortality

March 26, 2015

Middle-aged men with a high cardiorespiratory fitness level displayed decreased risks for lung and colon cancers, as well as a decreased risk for cancer-related death if diagnosed later in life, according to results of a prospective, observational analysis.

However, high fitness levels were not associated with a decreased risk for prostate cancer, the study researchers also found.

Fred Saad, MD In the Journals

Active surveillance may be appropriate for favorable intermediate-risk prostate cancer

March 20, 2015
Men with low-risk and favorable intermediate-risk prostate cancers demonstrated comparable risks for prostate cancer-specific and all-cause mortality 10 years after…
In the Journals

Low testosterone predicts improved outcomes with continuous ADT in prostate cancer

March 18, 2015
Patients with prostate cancer who achieved low nadir serum testosterone within the first year of continuous androgen-deprivation therapy demonstrated improved…
Daniel P.  Petrylak, MD In the Journals

Lenalidomide combination fails to improve survival in castration-resistant prostate cancer

March 13, 2015
The addition of lenalidomide to docetaxel and prednisone was associated with a significantly greater mortality rate in patients with metastatic castration-resistant…
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
Meeting News Coverage Video
Docetaxel plus ADT improved OS in metastatic prostate cancer th

Docetaxel plus ADT improved OS in metastatic prostate cancer

June 24, 2014
CHICAGO — Donald L. Trump, MD, FACP, president and CEO at Roswell Park Cancer Institute and HemOnc Today
More »
CME CNE
High Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 2 High Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Susan G. Lakoski, MD, MS In the Journals

Cardiorespiratory fitness levels predict risk for cancer diagnosis, mortality

March 26, 2015
Middle-aged men with a high cardiorespiratory fitness level displayed decreased risks for lung and colon cancers, as well as a decreased risk for…
Fred Saad, MD In the Journals

Active surveillance may be appropriate for favorable intermediate-risk prostate cancer

March 20, 2015
Men with low-risk and favorable intermediate-risk prostate cancers demonstrated comparable risks for prostate cancer-specific and all-cause mortality…
In the Journals

Low testosterone predicts improved outcomes with continuous ADT in prostate cancer

March 18, 2015
Patients with prostate cancer who achieved low nadir serum testosterone within the first year of continuous androgen-deprivation therapy demonstrated…
Daniel P.  Petrylak, MD In the Journals

Lenalidomide combination fails to improve survival in castration-resistant prostate cancer

March 13, 2015
The addition of lenalidomide to docetaxel and prednisone was associated with a significantly greater mortality rate in patients with metastatic…
In the Journals

Inappropriate breast, prostate cancer imaging linked to regional, culture infrastructure

March 12, 2015
High rates of inappropriate imaging for prostate cancer in hospital referral regions were associated with similarly inappropriate rates for breast…
In the Journals

Prostate cancer diagnosis in first-degree relative increases woman's risk for breast cancer

March 11, 2015
Women who have a first-degree relative diagnosed with prostate cancer demonstrated an increased risk for breast cancer after age 50 years, according…
In the Journals

ADT increases risk for cardiovascular disease in men with prostate cancer

March 5, 2015
Patients with prostate cancer who received androgen-deprivation therapy demonstrated an increased risk for cardiovascular disease, according to study…
Andrew Loblaw, MD Meeting News Coverage

Active surveillance not appropriate for all patients with intermediate-risk prostate cancer

February 25, 2015
Although active surveillance is acceptable for low-risk prostate cancers, the strategy may be risky for patients with intermediate-risk disease…
Emmanuel S. Antonarakis, MBBCh Meeting News Coverage

AR-V7 status not associated with taxane chemotherapy resistance in advanced prostate cancer

February 24, 2015
Men with metastatic castration-resistant prostate cancer demonstrated similar responses to taxane chemotherapy regardless of whether they had…
Meeting News Coverage

Testicular cancer may elevate risk for intermediate- or high-risk prostate cancer

February 23, 2015
Although risk remains low, men who have had testicular cancer appear more likely to develop intermediate- or high-risk prostate cancer, according to…
More Headlines »
morganatic-roan